D
Foghorn Therapeutics Inc. FHTX
$4.50 $0.081.81% NASDAQ
Recommendation
Prev Close
$4.50
Volume
184,543
Avg Vol (90D)
121,467
Market Cap
$254.38M
Dividend & Yield
--
52-Week Range
$2.94 - $9.70
P/E (TTM)
--
EPS (TTM)
-$1.20
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Foghorn Therapeutics (FHTX, $4.5) Aroon Indicator entered a Downtrend on October 08, 2025.
10/9/2025 - Tickeron - Stocks
Foghorn Therapeutics (NASDAQ:FHTX) Given Sell (D-) Rating at Weiss Ratings
10/9/2025 - MarketBeat
Foghorn Therapeutics (FHTX, $4.42) Aroon Indicator entered a Downtrend on October 07, 2025.
10/8/2025 - Tickeron - Stocks
Analysts Forecast 16% Gains Ahead For VTWO
10/7/2025 - ETF Channel
Foghorn Therapeutics (FHTX, $4.53) Aroon Indicator entered a Downtrend on October 06, 2025.
10/7/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $4.54) entered Downtrend as Momentum indicator drops below 0 level on Oct 02, 2025
10/3/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $4.93) entered Uptrend as Momentum indicator ascends above 0 level on Oct 01, 2025
10/2/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $4.89) entered Downtrend as Momentum indicator drops below 0 level on Sep 30, 2025
10/1/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $5.01) entered Uptrend as Momentum indicator ascends above 0 level on Sep 29, 2025
9/30/2025 - Tickeron - Stocks
Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of "Buy" from Analysts
9/24/2025 - Ticker Report
Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of "Buy" from Analysts
9/18/2025 - MarketBeat
B. Riley Initiates Coverage on Foghorn Therapeutics (NASDAQ:FHTX)
9/18/2025 - MarketBeat
Foghorn Therapeutics Breaks Below 200-Day Moving Average - Notable for FHTX
9/18/2025 - Market News Video
Foghorn Therapeutics (FHTX) Receives Buy Rating with $10 Target
9/17/2025 - GuruFocus
Foghorn Therapeutics transferred with Buy rating at B. Riley
9/17/2025 - The Fly
Foghorn Therapeutics (FHTX, $4.99) entered Downtrend as Momentum indicator drops below 0 level on Sep 15, 2025
9/16/2025 - Tickeron - Stocks
SCS Capital Management LLC Acquires Shares of 106,980 Foghorn Therapeutics Inc. $FHTX
9/14/2025 - MarketBeat
Foghorn Therapeutics (FHTX, $5.19) entered Uptrend as Momentum indicator ascends above 0 level on Sep 12, 2025
9/13/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $5.19) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 12, 2025
9/13/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $5.15) entered Downtrend as Momentum indicator drops below 0 level on Sep 10, 2025
9/11/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $5.15) price exceeded its 50-day Moving Average on September 10, 2025
9/11/2025 - Tickeron - Stocks
We Think Foghorn Therapeutics (NASDAQ:FHTX) Needs To Drive Business Growth Carefully
9/7/2025 - Simply Wall St
Foghorn Therapeutics (FHTX, $5.77) Stochastic Oscillator left the overbought zone on September 05, 2025
9/6/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $5.77) price may drop as it broke higher Bollinger Band on Sep 05, 2025
9/6/2025 - Tickeron - Stocks
Foghorn Therapeutics (FHTX, $5.39) price moved above its 50-day Moving Average on September 04, 2025
9/5/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$24.17M
EBITDA (TTM)
-$88.70M
EBIT (TTM)
-$91.87M
Net Income (TTM)
-$75.40M
Balance Sheet
Total Assets (Q)
$226.24M
Total Debt (Q)
$23.70M
Total Liabilities (Q)
$302.90M
Book Value Per Share (Q)
-$1.37
Cash Flow
Cash from Operations (TTM)
-$90.49M
Cash from Investing (TTM)
$24.21M
Cash from Financing (TTM)
$1.45M
Net Change in Cash (TTM)
-$64.83M
Filings
Filing Date
Tuesday, August 5, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
2.41
7-Day Total Return
-7.98%
30-Day Total Return
-16.82%
60-Day Total Return
-23.47%
90-Day Total Return
7.91%
Year to Date Total Return
-1.96%
1-Year Total Return
-38.02%
2-Year Total Return
30.06%
3-Year Total Return
-41.86%
5-Year Total Return
--
52-week Low
Apr 03, 2025 - $2.94
52-week High
Nov 11, 2024 - $9.70
Valuation
Market Cap
$254.38M - Micro Cap
Enterprise Value
$79.42M
Price/Sales (TTM)
11.72
Price/Book (Q)
-3.28
Dividends and Shares
Shares Outstanding
62.98
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
foghorntx.com
Phone Number
617 586 3100
Address
500 Technology Square
Cambridge, MA 02139
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin... more
NASDAQ 10/08/2025 4:00PM Eastern Quotes delayed